Cypress Semiconductor Corp. (NASDAQ: CY) today announced its
fourth-quarter 2013 and fiscal year 2013 results, which included the
remarks below from its president and CEO, T.J. Rodgers. Highlights for
the quarter included:
-
Earnings came in at high end of guidance
-
Book-to-bill increased to 1.08, its highest level in almost two years
-
Non-GAAP operating expenses at a 14-year low
-
Dividend yield was 4.3% with favorable tax treatment
Fellow shareholders:
Our revenue and earnings for the quarter are given below, compared with
those of the prior quarter and prior year:
(In thousands, except per-share data)
|
|
|
|
|
|
|
|
|
NON-GAAP
|
|
GAAP
|
|
|
|
Q4 2013
|
|
Q3 2013
|
|
Q4 2012
|
|
Q4 2013
|
|
Q3 2013
|
|
Q4 2012
|
|
Revenue
|
|
$
|
167,776
|
|
|
$
|
188,723
|
|
|
$
|
180,283
|
|
|
$
|
167,776
|
|
|
$
|
188,723
|
|
|
$
|
180,283
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross margin
|
|
|
51.0
|
%
|
|
|
53.8
|
%
|
|
|
51.5
|
%
|
|
|
45.6
|
%
|
|
|
48.6
|
%
|
|
|
46.7
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pretax margin
|
|
|
9.4
|
%
|
|
|
12.5
|
%
|
|
|
4.4
|
%
|
|
|
-7.0
|
%
|
|
|
-5.1
|
%
|
|
|
-12.9
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$
|
14,992
|
|
|
$
|
22,015
|
|
|
$
|
8,300
|
|
|
$
|
(13,577
|
)
|
|
$
|
(8,358
|
)
|
|
$
|
(22,219
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted EPS (loss)
|
|
$
|
0.09
|
|
|
$
|
0.14
|
|
|
$
|
0.05
|
|
|
$
|
(0.09
|
)
|
|
$
|
(0.06
|
)
|
|
$
|
(0.15
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Our revenue and earnings for the fiscal year are given below, compared
with those of the prior year:
(In thousands, except per-share data)
|
|
|
|
|
|
|
|
|
NON-GAAP
|
|
GAAP
|
|
|
|
FY 2013
|
|
FY 2012
|
|
FY 2013
|
|
FY 2012
|
|
Revenue
|
|
$
|
722,693
|
|
|
$
|
769,687
|
|
|
$
|
722,693
|
|
|
$
|
769,687
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross margin
|
|
|
52.2
|
%
|
|
|
55.4
|
%
|
|
|
46.9
|
%
|
|
|
51.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
Pretax margin
|
|
|
9.1
|
%
|
|
|
12.2
|
%
|
|
|
-7.7
|
%
|
|
|
-2.8
|
%
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$
|
63,221
|
|
|
$
|
91,450
|
|
|
$
|
(43,364
|
)
|
|
$
|
(22,370
|
)
|
|
|
|
|
|
|
|
|
|
|
|
Diluted EPS (loss)
|
|
$
|
0.39
|
|
|
$
|
0.55
|
|
|
$
|
(0.31
|
)
|
|
$
|
(0.15
|
)
|
|
|
|
|
|
|
|
|
|
|
Our fourth-quarter revenue of $167.8 million was above the midpoint of
our guidance, but down 11% from the $188.7 million in revenue of the
prior quarter. All divisions experienced normal seasonal declines. We
continued to execute very well on our operating expense management
initiatives, enabling us to deliver earnings at the high end of our
guidance. We thus are prepared to deliver strong operating leverage as
we return to revenue growth in 2014.
We exited 2013 with a book-to-bill ratio of 1.08, a high point since the
first quarter of 2012. The book-to-bill ratio of all divisions was above
unity with our Programmable Systems Division leading the way at 1.15.
Lead times remain low; our distributors decreased their inventories to
their lowest levels in three years. As such, we expect less-than-normal
seasonal revenue declines in the first quarter of 2014. Our design win
pipeline for our new TrueTouch® touchscreen products is
finally beginning to recover. We expect our revenue to remain in a
seasonal trough in the first quarter and then to increase during the
rest of 2014.
Note that we produced $167.8 million in revenue in the fourth quarter of
2013 vs. $180.3 million in the fourth quarter of 2012, down $12.5
million, but that our pretax profit was still up $7.9 million. This was
due to record-low operating expenses.
BUSINESS REVIEW
+ Our non-GAAP consolidated gross margin for the fourth quarter was
51.0%, down 2.8 percentage points from the previous quarter, due
primarily to reduced amortization of manufacturing expenses by lower
revenue. Excluding our Emerging Technologies Division (ETD), our core
semiconductor gross margin was 52.3%. ETD revenue is growing rapidly
(see Net Sales Summary table) and will contribute significantly to
revenue growth in 2014.
+ Net inventory at the end of the fourth quarter was $100.6 million,
down from the third quarter.
|
|
|
NET SALES SUMMARY
|
|
(In thousands, except percentages)
|
|
(Unaudited)
|
|
|
|
|
|
THREE MONTHS ENDED
|
|
|
|
|
Dec. 29,
|
|
Sept. 29,
|
|
Dec. 30,
|
|
Sequential
|
|
Year-over-
|
|
Business Unit
|
|
2013
|
|
2013
|
|
2012
|
|
Change
|
|
Year Change
|
|
PSD1
|
|
$
|
67,746
|
|
|
$
|
78,135
|
|
|
$
|
81,405
|
|
|
-13
|
%
|
|
-17
|
%
|
|
MPD1
|
|
$
|
79,890
|
|
|
$
|
88,743
|
|
|
$
|
77,421
|
|
|
-10
|
%
|
|
3
|
%
|
|
DCD1
|
|
$
|
16,482
|
|
|
$
|
18,884
|
|
|
$
|
20,170
|
|
|
-13
|
%
|
|
-18
|
%
|
|
ETD1, 2
|
|
$
|
3,658
|
|
|
$
|
2,961
|
|
|
$
|
1,287
|
|
|
24
|
%
|
|
184
|
%
|
|
Total
|
|
$
|
167,776
|
|
|
$
|
188,723
|
|
|
$
|
180,283
|
|
|
-11
|
%
|
|
-7
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Geographic
|
|
|
|
|
|
|
|
|
|
|
|
China and ROW
|
|
|
64
|
%
|
|
|
64
|
%
|
|
|
68
|
%
|
|
0
|
%
|
|
-6
|
%
|
|
Americas
|
|
|
14
|
%
|
|
|
14
|
%
|
|
|
16
|
%
|
|
0
|
%
|
|
-13
|
%
|
|
Europe
|
|
|
12
|
%
|
|
|
12
|
%
|
|
|
9
|
%
|
|
0
|
%
|
|
33
|
%
|
|
Japan
|
|
|
10
|
%
|
|
|
10
|
%
|
|
|
7
|
%
|
|
0
|
%
|
|
43
|
%
|
|
Total
|
|
|
100
|
%
|
|
|
100
|
%
|
|
|
100
|
%
|
|
0
|
%
|
|
0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Channel
|
|
|
|
|
|
|
|
|
|
|
|
Distribution
|
|
|
69
|
%
|
|
|
74
|
%
|
|
|
75
|
%
|
|
-7
|
%
|
|
-8
|
%
|
|
Direct
|
|
|
31
|
%
|
|
|
26
|
%
|
|
|
25
|
%
|
|
19
|
%
|
|
24
|
%
|
|
Total
|
|
|
100
|
%
|
|
|
100
|
%
|
|
|
100
|
%
|
|
0
|
%
|
|
0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TWELVE MONTHS ENDED
|
|
|
|
|
Dec. 29,
|
|
Dec. 30,
|
|
Year-over-
|
|
Business Unit
|
|
2013
|
|
2012
|
|
Year Change
|
|
PSD1
|
|
$
|
292,707
|
|
|
$
|
345,430
|
|
|
-15
|
%
|
|
MPD1
|
|
$
|
338,986
|
|
|
$
|
330,504
|
|
|
3
|
%
|
|
DCD1
|
|
$
|
79,410
|
|
|
$
|
86,591
|
|
|
-8
|
%
|
|
ETD1, 2
|
|
$
|
11,590
|
|
|
$
|
7,162
|
|
|
62
|
%
|
|
Total
|
|
$
|
722,693
|
|
|
$
|
769,687
|
|
|
-6
|
%
|
|
|
|
|
|
|
|
|
|
Geographic
|
|
|
|
|
|
|
|
China and ROW
|
|
|
66
|
%
|
|
|
65
|
%
|
|
2
|
%
|
|
Americas
|
|
|
14
|
%
|
|
|
17
|
%
|
|
-18
|
%
|
|
Europe
|
|
|
11
|
%
|
|
|
10
|
%
|
|
10
|
%
|
|
Japan
|
|
|
9
|
%
|
|
|
8
|
%
|
|
13
|
%
|
|
Total
|
|
|
100
|
%
|
|
|
100
|
%
|
|
0
|
%
|
|
|
|
|
|
|
|
|
|
Channel
|
|
|
|
|
|
|
|
Distribution
|
|
|
73
|
%
|
|
|
74
|
%
|
|
-1
|
%
|
|
Direct
|
|
|
27
|
%
|
|
|
26
|
%
|
|
4
|
%
|
|
Total
|
|
|
100
|
%
|
|
|
100
|
%
|
|
0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1.
|
|
PSD, Programmable Systems Division; DCD, Data Communications
Division; MPD, Memory Products Division: ETD, Emerging Technology
Division.
|
|
|
2.
|
|
“Emerging Technology” includes businesses outside our core
semiconductor businesses outlined in Footnote 1. Includes
subsidiaries AgigA Tech Inc., Deca Technologies Inc., and our
foundry business unit
|
.
|
FOURTH-QUARTER 2013 HIGHLIGHTS
+ Cypress was issued its one-hundredth patent for its TrueTouch®
capacitive touchscreen controllers. The patent relates to the TrueTouch
Gen5 family’s unmatched immunity to electrical noise from chargers and
displays, which can render touchscreens unusable. The company continues
to expand its touch patent portfolio, with more than 200 patents pending.
+ Cypress announced that its partnership with Fujifilm of Japan has
created new TrueTouch controllers that support Fujifilm’s metal mesh
sensors. Cypress believes these sensors to be the most advanced and
cost-effective on the market. Metal mesh sensors deliver significantly
better scanning performance than traditional indium tin oxide (ITO)
sensors.
+ Cypress shipped its one-billionth CapSense® capacitive
touch-sensing controller. Cypress's CapSense solutions have replaced
more than five billion mechanical buttons, producing four times the
revenue of its nearest competitor.
+ The research and analytics firm Chipworks noted the use of a Cypress
CapSense controller in a recent teardown of the Samsung Galaxy Note 3
smartphone. The teardown also determined that the controller enables the
ability to register touches from users wearing gloves.
+ Cypress held a global design competition promoting the use of its new
PSoC® 4 programmable system-on-chip to develop intelligent,
forward-looking embedded systems for homes, offices and cars. The design
challenge was based on the easy-to-use PSoC 4 Pioneer Kit, which just
won distributor element14’s development kit of the year award, beating
entries from Texas Instruments and Freescale.
+ Digital multimedia supplier AVerMedia Technologies selected Cypress’s
EZ-USB® FX3™ (USB 3.0) controller for its new high-definition
(HD) video capture card. AVerMedia’s ExtremeCap U3 card records and
streams game play at full HD resolution. The card uses the 5-Gbps FX3
solution to capture HD video without compression, improving image
quality.
+ Cypress announced production availability of the CYFB0072 high-density
video frame buffer, which addresses the increasing demand for
high-bandwidth video buffering. The device contains 72 Mbits of
high-performance SRAM in an interface that simplifies implementation and
debugging.
+ Seiko Epson selected Cypress’s CY5077C programmable clock generator
die for its new SG-8003CG programmable crystal oscillator. The die
delivers precise, programmable frequency output to the ultra-small
oscillator. The flexible combination provides fast time-to-market and
low power consumption for a wide variety of electronics equipment.
Cypress has shipped a cumulative 880 million crystal oscillator chips.
+ L-3 Cincinnati Electronics, a division of L-3 Communications, selected
Cypress to manufacture its Readout Integrated Circuits (ROICs). L-3 will
use the proprietary process technology of Cypress’s wafer fabrication
facility in Bloomington, Minnesota to design and manufacture these ROICs
for its cooled infrared detectors.
+ D-Wave Systems successfully transferred its proprietary process
technology for building quantum computing microprocessors to Cypress’s
wafer foundry in Bloomington.
+ Cypress announced that its Board of Directors approved a quarterly
cash dividend of $0.11 per share, payable to holders of record of the
company’s common stock as of the close of business on December 26, 2013.
This dividend was paid on January 16, 2014.
Learn More About Cypress
ABOUT CYPRESS
Cypress delivers high-performance, mixed-signal, programmable solutions
that provide customers with rapid time-to-market and exceptional system
value. Cypress offerings include the flagship PSoC 1, PSoC 3, PSoC 4 and
PSoC 5LP programmable system-on-chip families. Cypress is the world
leader in capacitive user interface solutions including CapSense touch
sensing, TrueTouch touchscreens, and trackpad solutions for notebook PCs
and peripherals. Cypress is a world leader in USB controllers, which
enhance connectivity and performance in a wide range of consumer and
industrial products. Cypress is also the world leader in SRAM and
nonvolatile RAM memories. Cypress serves numerous major markets,
including consumer, mobile handsets, computation, data communications,
automotive, industrial and military. Cypress trades on the NASDAQ Global
Select Market under the ticker symbol CY. Visit Cypress online at www.cypress.com.
FORWARD-LOOKING STATEMENTS
Statements herein that are not historical facts and that refer to
Cypress or its subsidiaries’ plans and expectations for Q1 2014 and the
remainder of fiscal year 2014 and beyond are forward-looking statements
made pursuant to the Private Securities Litigation Reform Act of 1995.
We may use words such as “believe,” “expect,” “future,” “plan,” “intend”
and similar expressions to identify such forward-looking statements that
include, but are not limited to, statements related to the semiconductor
market; the strength and growth of our proprietary and programmable
products; our expectation that we will experience a less than normal
seasonal revenue decline in Q1 2014 and then increase during the rest of
2014; our expectation related to our earnings leverage, margins,
profit, cash flow and cost-saving measures; our expectation that our ETD
division will contribute to our 2014 revenue; our expectations regarding
the demand for our products and how our products are expected to
perform, including the expected recovery of our TrueTouch touchscreen
design win pipeline, as well as our future design win expectations for
other products and market share gains. Such statements reflect our
current expectations, which are based on information and data available
to our management as of the date of this release. Our actual results may
differ materially due to a variety of uncertainties and risk factors,
including, but not limited to, the state of and future of the global
economy, business conditions and growth trends in the semiconductor
market, whether our products perform as expected, whether the demand for
our proprietary and programmable products is fully realized, whether our
product and design wins and kit sales result in increased sales, our
ability to manage our business to have strong earnings, reduce operating
expenses, factory utilization, the strength or softness of the markets
we serve, our ability to maintain and improve our gross margins and
realize our bookings, the seasonality of the markets we serve, the
financial performance of our subsidiaries and Emerging Technology
Division, and other risks described in our filings with the Securities
and Exchange Commission. We assume no responsibility to update any such
forward-looking statements.
Cypress, the Cypress logo, PSoC, TrueTouch, EZ-USB and CapSense are
registered trademarks and FX3 is a trademark of Cypress Semiconductor
Corp. All other trademarks or registered trademarks are the property of
their respective owners.
|
|
|
CYPRESS SEMICONDUCTOR CORPORATION
|
|
CONDENSED CONSOLIDATED BALANCE SHEETS
|
|
(In thousands)
|
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
December 29,
|
|
December 30,
|
|
|
|
2013
|
|
2012
|
|
|
|
|
|
|
|
ASSETS
|
|
|
|
|
|
|
|
|
|
|
|
Cash, cash equivalents and short-term investments
|
|
$
|
104,462
|
|
|
$
|
117,210
|
|
|
Accounts receivable, net
|
|
|
81,084
|
|
|
|
82,920
|
|
|
Inventories (a)
|
|
|
100,612
|
|
|
|
127,596
|
|
|
Property, plant and equipment, net
|
|
|
258,585
|
|
|
|
274,427
|
|
|
Goodwill and other intangible assets, net
|
|
|
106,523
|
|
|
|
113,410
|
|
|
Other assets
|
|
|
113,707
|
|
|
|
116,066
|
|
|
Total assets
|
|
$
|
764,973
|
|
|
$
|
831,629
|
|
|
|
|
|
|
|
|
LIABILITIES AND EQUITY
|
|
|
|
|
|
|
|
|
|
|
|
Accounts payable
|
|
$
|
47,893
|
|
|
$
|
58,704
|
|
|
Deferred margin on sales to distributors
|
|
|
122,578
|
|
|
|
131,192
|
|
|
Income tax liabilities
|
|
|
29,001
|
|
|
|
47,454
|
|
|
Other liabilities
|
|
|
159,866
|
|
|
|
185,418
|
|
|
Long-term revolving credit facility
|
|
|
227,000
|
|
|
|
232,000
|
|
|
Total liabilities
|
|
|
586,338
|
|
|
|
654,768
|
|
|
Total Cypress stockholders' equity
|
|
|
183,109
|
|
|
|
180,900
|
|
|
Noncontrolling interest
|
|
|
(4,474
|
)
|
|
|
(4,039
|
)
|
|
Total equity
|
|
|
178,635
|
|
|
|
176,861
|
|
|
Total liabilities and equity
|
|
$
|
764,973
|
|
|
$
|
831,629
|
|
|
|
|
|
|
|
|
(a)
|
|
Inventories include $5.3 million and $2.8 million of capitalized
inventories related to stock-based compensation expense, as of
December 29, 2013 and December 30, 2012, respectively.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CYPRESS SEMICONDUCTOR CORPORATION
|
|
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
|
|
ON A GAAP BASIS
|
|
(In thousands, except per-share data)
|
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
Twelve Months Ended
|
|
|
|
December 29,
|
|
September 29,
|
|
December 30,
|
|
|
December 29,
|
|
December 30,
|
|
|
|
2013
|
|
2013
|
|
2012
|
|
|
2013
|
|
2012
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues
|
|
$
|
167,776
|
|
|
$
|
188,723
|
|
|
$
|
180,282
|
|
|
|
$
|
722,693
|
|
|
$
|
769,687
|
|
|
Cost of revenues
|
|
|
91,328
|
|
|
|
97,070
|
|
|
|
96,088
|
|
|
|
|
384,121
|
|
|
|
376,887
|
|
|
Gross margin
|
|
|
76,448
|
|
|
|
91,653
|
|
|
|
84,194
|
|
|
|
|
338,572
|
|
|
|
392,800
|
|
|
Operating expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
Research and development
|
|
|
42,343
|
|
|
|
50,429
|
|
|
|
47,075
|
|
|
|
|
190,906
|
|
|
|
189,897
|
|
|
Selling, general and administrative
|
|
|
43,623
|
|
|
|
45,533
|
|
|
|
52,183
|
|
|
|
|
182,671
|
|
|
|
211,959
|
|
|
Amortization of acquisition-related intangibles
|
|
|
1,850
|
|
|
|
1,987
|
|
|
|
1,826
|
|
|
|
|
7,833
|
|
|
|
3,996
|
|
|
Restructuring charges
|
|
|
(469
|
)
|
|
|
3,693
|
|
|
|
2,976
|
|
|
|
|
15,357
|
|
|
|
4,258
|
|
|
Loss on divestiture
|
|
|
-
|
|
|
|
-
|
|
|
|
1,605
|
|
|
|
|
-
|
|
|
|
1,605
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating expenses, net
|
|
|
87,347
|
|
|
|
101,642
|
|
|
|
105,665
|
|
|
|
|
396,767
|
|
|
|
411,715
|
|
|
Operating income (loss)
|
|
|
(10,899
|
)
|
|
|
(9,989
|
)
|
|
|
(21,471
|
)
|
|
|
|
(58,195
|
)
|
|
|
(18,915
|
)
|
|
Interest and other income (expense), net
|
|
|
(805
|
)
|
|
|
427
|
|
|
|
(1,749
|
)
|
|
|
|
2,225
|
|
|
|
(2,745
|
)
|
|
Income (loss) before income taxes
|
|
|
-
|
|
|
|
(9,562
|
)
|
|
|
(23,220
|
)
|
|
|
|
(55,970
|
)
|
|
|
(21,660
|
)
|
|
Income tax provision (benefit)
|
|
|
2,210
|
|
|
|
(774
|
)
|
|
|
417
|
|
|
|
|
(7,761
|
)
|
|
|
2,324
|
|
|
Income (loss), net of taxes
|
|
|
(13,914
|
)
|
|
|
(8,788
|
)
|
|
|
(22,803
|
)
|
|
|
|
(48,209
|
)
|
|
|
(23,984
|
)
|
|
Adjust for net loss attributable to noncontrolling interest
|
|
|
337
|
|
|
|
430
|
|
|
|
584
|
|
|
|
|
1,845
|
|
|
|
1,614
|
|
|
Net income (loss) attributable to Cypress
|
|
$
|
(13,577
|
)
|
|
$
|
(8,358
|
)
|
|
$
|
(22,219
|
)
|
|
|
$
|
(46,364
|
)
|
|
$
|
(22,370
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) per share attributable to Cypress:
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
(0.09
|
)
|
|
$
|
(0.06
|
)
|
|
$
|
(0.15
|
)
|
|
|
$
|
(0.31
|
)
|
|
$
|
(0.15
|
)
|
|
Diluted
|
|
$
|
(0.09
|
)
|
|
$
|
(0.06
|
)
|
|
$
|
(0.15
|
)
|
|
|
$
|
(0.31
|
)
|
|
$
|
(0.15
|
)
|
|
Cash dividend declared per share
|
|
$
|
0.11
|
|
|
$
|
0.11
|
|
|
$
|
0.11
|
|
|
|
$
|
0.44
|
|
|
$
|
0.44
|
|
|
Shares used in net income (loss) per share calculation:
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
151,580
|
|
|
|
149,679
|
|
|
|
143,605
|
|
|
|
|
148,558
|
|
|
|
149,266
|
|
|
Diluted
|
|
|
151,580
|
|
|
|
149,679
|
|
|
|
143,605
|
|
|
|
|
148,558
|
|
|
|
149,266
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CYPRESS SEMICONDUCTOR CORPORATION
|
|
RECONCILIATION OF GAAP FINANCIAL MEASURES TO NON-GAAP FINANCIAL
MEASURES (a)
|
|
(In thousands, except per-share data)
|
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
Twelve Months Ended
|
|
|
|
December 29,
|
|
September 29,
|
|
December 30,
|
|
|
December 29,
|
|
December 30,
|
|
|
|
2013
|
|
2013
|
|
2012
|
|
|
2013
|
|
2012
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP gross margin
|
|
$
|
76,448
|
|
|
$
|
91,653
|
|
|
$
|
84,194
|
|
|
|
$
|
338,572
|
|
|
$
|
392,800
|
|
|
Stock-based compensation expense
|
|
|
3,088
|
|
|
|
2,804
|
|
|
|
2,195
|
|
|
|
|
12,789
|
|
|
|
18,519
|
|
|
Acquisition-related expense
|
|
|
5,562
|
|
|
|
6,849
|
|
|
|
3,545
|
|
|
|
|
24,805
|
|
|
|
3,545
|
|
|
Changes in value of deferred compensation plan
|
|
|
136
|
|
|
|
265
|
|
|
|
(66
|
)
|
|
|
|
854
|
|
|
|
372
|
|
|
Impairment of assets and other
|
|
|
269
|
|
|
|
(64
|
)
|
|
|
2,137
|
|
|
|
|
241
|
|
|
|
3,581
|
|
|
Patent license fee
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
|
-
|
|
|
|
7,100
|
|
|
(Gain) loss on divestiture
|
|
|
-
|
|
|
|
-
|
|
|
|
776
|
|
|
|
|
-
|
|
|
|
776
|
|
|
Non-GAAP gross margin
|
|
$
|
85,503
|
|
|
$
|
101,507
|
|
|
$
|
92,781
|
|
|
|
$
|
377,261
|
|
|
$
|
426,693
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP research and development expenses
|
|
$
|
42,343
|
|
|
$
|
50,429
|
|
|
$
|
47,074
|
|
|
|
$
|
190,906
|
|
|
$
|
189,897
|
|
|
Stock-based compensation expense
|
|
|
(7,356
|
)
|
|
|
(6,806
|
)
|
|
|
(2,345
|
)
|
|
|
|
(26,042
|
)
|
|
|
(19,800
|
)
|
|
Acquisition-related expense
|
|
|
-
|
|
|
|
(19
|
)
|
|
|
(2,703
|
)
|
|
|
|
(252
|
)
|
|
|
(2,703
|
)
|
|
Non-cash compensation
|
|
|
-
|
|
|
|
-
|
|
|
|
(433
|
)
|
|
|
|
-
|
|
|
|
(433
|
)
|
|
Changes in value of deferred compensation plan
|
|
|
(282
|
)
|
|
|
(548
|
)
|
|
|
155
|
|
|
|
|
(1,744
|
)
|
|
|
(568
|
)
|
|
(Gain) loss on divestiture
|
|
|
-
|
|
|
|
-
|
|
|
|
(306
|
)
|
|
|
|
-
|
|
|
|
(307
|
)
|
|
Impairment of assets and other
|
|
|
1,368
|
|
|
|
(1,078
|
)
|
|
|
-
|
|
|
|
|
(1,104
|
)
|
|
|
-
|
|
|
Non-GAAP research and development expenses
|
|
$
|
36,074
|
|
|
$
|
41,978
|
|
|
$
|
41,442
|
|
|
|
$
|
161,764
|
|
|
$
|
166,086
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP selling, general and administrative expenses
|
|
$
|
43,623
|
|
|
$
|
45,533
|
|
|
$
|
52,182
|
|
|
|
$
|
182,671
|
|
|
$
|
211,959
|
|
|
Stock-based compensation expense
|
|
|
(10,432
|
)
|
|
|
(9,701
|
)
|
|
|
(2,724
|
)
|
|
|
|
(34,187
|
)
|
|
|
(36,013
|
)
|
|
Acquisition-related expense
|
|
|
(148
|
)
|
|
|
(366
|
)
|
|
|
(6,545
|
)
|
|
|
|
(1,168
|
)
|
|
|
(9,095
|
)
|
|
Non-cash compensation
|
|
|
-
|
|
|
|
-
|
|
|
|
(500
|
)
|
|
|
|
-
|
|
|
|
(500
|
)
|
|
Changes in value of deferred compensation plan
|
|
|
(607
|
)
|
|
|
(1,181
|
)
|
|
|
306
|
|
|
|
|
(3,795
|
)
|
|
|
(1,710
|
)
|
|
Impairment of assets and other
|
|
|
(244
|
)
|
|
|
131
|
|
|
|
(220
|
)
|
|
|
|
(450
|
)
|
|
|
(173
|
)
|
|
(Gain) loss on divestiture
|
|
|
-
|
|
|
|
-
|
|
|
|
(664
|
)
|
|
|
|
-
|
|
|
|
(664
|
)
|
|
Non-GAAP selling, general and administrative expenses
|
|
$
|
32,192
|
|
|
$
|
34,416
|
|
|
$
|
41,835
|
|
|
|
$
|
143,071
|
|
|
$
|
163,804
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP operating income (loss)
|
|
$
|
(10,899
|
)
|
|
$
|
(9,989
|
)
|
|
$
|
(21,470
|
)
|
|
|
|
(58,195
|
)
|
|
$
|
(18,915
|
)
|
|
Stock-based compensation expense
|
|
|
20,877
|
|
|
|
19,311
|
|
|
|
7,264
|
|
|
|
|
73,020
|
|
#
|
|
74,332
|
|
|
Acquisition-related expense
|
|
|
7,558
|
|
|
|
9,221
|
|
|
|
14,618
|
|
|
|
|
34,056
|
|
|
|
19,337
|
|
|
Non-cash compensation
|
|
|
-
|
|
|
|
-
|
|
|
|
933
|
|
|
|
|
-
|
|
|
|
933
|
|
|
Changes in value of deferred compensation plan
|
|
|
1,026
|
|
|
|
1,994
|
|
|
|
(528
|
)
|
|
|
|
6,393
|
|
|
|
2,650
|
|
|
Impairment of assets and other
|
|
|
(854
|
)
|
|
|
883
|
|
|
|
2,361
|
|
|
|
|
1,795
|
|
|
|
3,758
|
|
|
Restructuring charges
|
|
|
(470
|
)
|
|
|
3,693
|
|
|
|
2,975
|
|
|
|
|
15,357
|
|
|
|
4,258
|
|
|
Patent license fee
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
|
-
|
|
|
|
7,100
|
|
|
(Gain) loss on divestiture and expenses
|
|
|
-
|
|
|
|
-
|
|
|
|
3,351
|
|
|
|
|
-
|
|
|
|
3,351
|
|
|
Non-GAAP operating income
|
|
$
|
17,238
|
|
|
$
|
25,113
|
|
|
$
|
9,504
|
|
|
|
$
|
72,426
|
|
|
$
|
96,804
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP net income (loss) attributable to Cypress
|
|
$
|
(13,577
|
)
|
|
$
|
(8,358
|
)
|
|
$
|
(22,219
|
)
|
|
|
$
|
(46,364
|
)
|
|
$
|
(22,370
|
)
|
|
Stock-based compensation expense
|
|
|
20,877
|
|
|
|
19,311
|
|
|
|
7,264
|
|
|
|
|
73,020
|
|
|
|
74,332
|
|
|
Acquisition-related expense
|
|
|
7,558
|
|
|
|
9,221
|
|
|
|
14,618
|
|
|
|
|
34,056
|
|
|
|
19,337
|
|
|
Non-cash compensation
|
|
|
-
|
|
|
|
-
|
|
|
|
933
|
|
|
|
|
-
|
|
|
|
933
|
|
|
Changes in value of deferred compensation plan
|
|
|
(535
|
)
|
|
|
(97
|
)
|
|
|
(530
|
)
|
|
|
|
22
|
|
|
|
(507
|
)
|
|
Impairment of assets and other
|
|
|
(854
|
)
|
|
|
883
|
|
|
|
292
|
|
|
|
|
1,794
|
|
|
|
3,758
|
|
|
Restructuring charges
|
|
|
(470
|
)
|
|
|
3,693
|
|
|
|
2,975
|
|
|
|
|
15,357
|
|
|
|
4,258
|
|
|
Tax and tax-related items
|
|
|
1,065
|
|
|
|
(2,638
|
)
|
|
|
(555
|
)
|
|
|
|
(12,398
|
)
|
|
|
(1,502
|
)
|
|
Investment-related gains/losses
|
|
|
930
|
|
|
|
-
|
|
|
|
2,171
|
|
|
|
|
(2,266
|
)
|
|
|
2,760
|
|
|
Patent license fee
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
|
-
|
|
|
|
7,100
|
|
|
(Gain) loss on divestiture and expenses
|
|
|
-
|
|
|
|
-
|
|
|
|
3,351
|
|
|
|
|
-
|
|
|
|
3,351
|
|
|
Non-GAAP net income attributable to Cypress
|
|
$
|
14,994
|
|
|
$
|
22,015
|
|
|
$
|
8,300
|
|
|
|
$
|
63,221
|
|
|
$
|
91,450
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP net income (loss) per share attributable to Cypress - diluted
|
|
$
|
(0.09
|
)
|
|
$
|
(0.06
|
)
|
|
$
|
(0.15
|
)
|
|
|
$
|
(0.31
|
)
|
|
$
|
(0.15
|
)
|
|
Stock-based compensation expense
|
|
|
0.13
|
|
|
|
0.12
|
|
|
|
0.04
|
|
|
|
|
0.45
|
|
|
|
0.45
|
|
|
Acquisition-related expense
|
|
|
0.05
|
|
|
|
0.02
|
|
|
|
0.08
|
|
|
|
|
0.21
|
|
|
|
0.12
|
|
|
Impairment of assets and other
|
|
|
(0.01
|
)
|
|
|
0.05
|
|
|
|
-
|
|
|
|
|
0.01
|
|
|
|
0.02
|
|
|
Non-cash compensation
|
|
|
-
|
|
|
|
-
|
|
|
|
0.01
|
|
|
|
|
-
|
|
|
|
-
|
|
|
Restructuring charges
|
|
|
-
|
|
|
|
0.02
|
|
|
|
0.02
|
|
|
|
|
0.10
|
|
|
|
0.03
|
|
|
Tax and tax-related items
|
|
|
0.01
|
|
|
|
(0.02
|
)
|
|
|
-
|
|
|
|
|
(0.08
|
)
|
|
|
(0.01
|
)
|
|
Investment-related gains/losses
|
|
|
0.01
|
|
|
|
-
|
|
|
|
0.02
|
|
|
|
|
(0.01
|
)
|
|
|
0.02
|
|
|
Non-GAAP share count adjustment
|
|
|
(0.01
|
)
|
|
|
0.01
|
|
|
|
0.01
|
|
|
|
|
0.02
|
|
|
|
0.01
|
|
|
Patent license fee
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
|
-
|
|
|
|
0.04
|
|
|
(Gain) loss on divestiture and expenses
|
|
|
-
|
|
|
|
-
|
|
|
|
0.02
|
|
|
|
|
-
|
|
|
|
0.02
|
|
|
Non-GAAP net income per share attributable to Cypress - diluted
|
|
$
|
0.09
|
|
|
$
|
0.14
|
|
|
$
|
0.05
|
|
|
|
$
|
0.39
|
|
|
$
|
0.55
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a)
|
|
Refer to the accompanying "Notes to Non-GAAP Financial Measures"
for a detailed discussion of management's use of non-GAAP
financial measures.
|
|
|
|
CYPRESS SEMICONDUCTOR CORPORATION
|
|
SUPPLEMENTAL FINANCIAL DATA
|
|
(In thousands)
|
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
Twelve Months Ended
|
|
|
|
December 29,
|
|
September 29,
|
|
December 30,
|
|
|
December 29
|
|
December 30,
|
|
|
|
2013
|
|
2013
|
|
2012
|
|
|
2013
|
|
2012
|
|
Selected Cash Flow Data (Preliminary):
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by operating activities
|
|
$
|
20,171
|
|
|
$
|
7,905
|
|
|
$
|
17,302
|
|
|
|
$
|
66,696
|
|
|
$
|
134,997
|
|
|
Net cash provided by (used in) investing activities
|
|
$
|
569
|
|
|
$
|
(2,080
|
)
|
|
$
|
(95,562
|
)
|
|
|
$
|
1,139
|
|
|
$
|
(113,036
|
)
|
|
Net cash provided by (used in) financing activities
|
|
$
|
(11,276
|
)
|
|
$
|
108
|
|
|
$
|
(20,866
|
)
|
|
|
$
|
(45,024
|
)
|
|
$
|
(58,475
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Supplemental Data (Preliminary):
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital expenditures
|
|
$
|
8,750
|
|
|
$
|
10,808
|
|
|
$
|
7,809
|
|
|
|
$
|
36,627
|
|
|
$
|
33,013
|
|
|
Depreciation
|
|
$
|
9,436
|
|
|
$
|
9,745
|
|
|
$
|
11,419
|
|
|
|
$
|
39,572
|
|
|
$
|
44,904
|
|
|
Payment of dividend
|
|
$
|
16,578
|
|
|
$
|
16,258
|
|
|
$
|
16,057
|
|
|
|
$
|
64,819
|
|
|
$
|
63,227
|
|
|
Dividend paid per share
|
|
$
|
0.11
|
|
|
$
|
0.11
|
|
|
$
|
0.11
|
|
|
|
$
|
0.44
|
|
|
$
|
0.44
|
|
|
Dividend yield per share (a)
|
|
|
4.3
|
%
|
|
|
4.9
|
%
|
|
|
4.2
|
%
|
|
|
|
4.3
|
%
|
|
|
4.2
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a)
|
|
Dividend yield per share is calculated based on the annualized
dividend paid per share divided by the common stock share price at
the end of the period.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CYPRESS SEMICONDUCTOR CORPORATION
|
|
CONSOLIDATED DILUTED EPS CALCULATION
|
|
(In thousands, except per-share data)
|
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
Twelve Months Ended
|
|
|
|
December 29,
|
|
September 29,
|
|
December 30,
|
|
|
December 29,
|
|
December 30,
|
|
|
|
2013
|
|
2013
|
|
2012
|
|
|
2013
|
|
2012
|
|
|
|
GAAP
|
|
Non-GAAP
|
|
GAAP
|
|
Non-GAAP
|
|
GAAP
|
|
Non-GAAP
|
|
|
GAAP
|
|
Non-GAAP
|
|
GAAP
|
|
Non-GAAP
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) attributable to Cypress
|
|
$
|
(13,577
|
)
|
|
$
|
14,992
|
|
$
|
(8,358
|
)
|
|
$
|
22,015
|
|
$
|
(22,219
|
)
|
|
$
|
8,300
|
|
|
$
|
(46,364
|
)
|
|
$
|
63,221
|
|
$
|
(22,370
|
)
|
|
$
|
91,450
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average common shares outstanding (basic)
|
|
|
151,580
|
|
|
|
151,580
|
|
|
149,679
|
|
|
|
149,679
|
|
|
143,605
|
|
|
|
143,605
|
|
|
|
148,558
|
|
|
|
148,558
|
|
|
149,266
|
|
|
|
149,266
|
|
Effect of dilutive securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock options, unvested restricted stock and other
|
|
|
-
|
|
|
|
14,224
|
|
|
-
|
|
|
|
12,525
|
|
|
-
|
|
|
|
13,723
|
|
|
|
-
|
|
|
|
12,954
|
|
|
-
|
|
|
|
16,063
|
|
Weighted-average common shares outstanding for diluted computation
|
|
|
151,580
|
|
|
|
165,804
|
|
|
149,679
|
|
|
|
162,204
|
|
|
143,605
|
|
|
|
157,328
|
|
|
|
148,558
|
|
|
|
161,512
|
|
|
149,266
|
|
|
|
165,329
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) per share attributable to Cypress - basic
|
|
$
|
(0.09
|
)
|
|
$
|
0.10
|
|
$
|
(0.06
|
)
|
|
$
|
0.15
|
|
$
|
(0.15
|
)
|
|
$
|
0.06
|
|
|
$
|
(0.31
|
)
|
|
$
|
0.43
|
|
$
|
(0.15
|
)
|
|
$
|
0.61
|
|
Net income (loss) per share attributable to Cypress - diluted
|
|
$
|
(0.09
|
)
|
|
$
|
0.09
|
|
$
|
(0.06
|
)
|
|
$
|
0.14
|
|
$
|
(0.15
|
)
|
|
$
|
0.05
|
|
|
$
|
(0.31
|
)
|
|
$
|
0.39
|
|
$
|
(0.15
|
)
|
|
$
|
0.55
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 29,
|
|
September 30,
|
|
December 30,
|
|
|
December 29,
|
|
December 30,
|
|
|
|
2013
|
|
2012
|
|
2012
|
|
|
2013
|
|
2012
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Average stock price for the period ended
|
|
$9.45
|
|
$11.70
|
|
$10.19
|
|
|
$10.59
|
|
$13.26
|
|
Common stock outstanding at period end (in thousands)
|
|
153,214
|
|
150,833
|
|
144,224
|
|
|
153,214
|
|
144,224
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Notes to Non-GAAP Financial Measures
To supplement its consolidated financial results presented in accordance
with GAAP, Cypress uses non-GAAP financial measures which are adjusted
from the most directly comparable GAAP financial measures to exclude
certain items, as described in details below. Management believes that
these non-GAAP financial measures reflect an additional and useful way
of viewing aspects of Cypress’s operations that, when viewed in
conjunction with Cypress’s GAAP results, provide a more comprehensive
understanding of the various factors and trends affecting Cypress’s
business and operations. Non-GAAP financial measures used by Cypress
include:
|
|
•
|
|
Research and development expenses;
|
|
|
•
|
|
Selling, general and administrative expenses;
|
|
|
•
|
|
Operating income (loss);
|
|
|
•
|
|
Diluted net income (loss) per share.
|
Cypress uses each of these non-GAAP financial measures for internal
managerial purposes, when providing its financial results and business
outlook to the public, and to facilitate period-to-period comparisons.
Management believes that these non-GAAP measures provide meaningful
supplemental information regarding Cypress’s operational and financial
performance of current and historical results. Management uses these
non-GAAP measures for strategic and business decision making, internal
budgeting, forecasting and resource allocation processes. In addition,
these non-GAAP financial measures facilitate management’s internal
comparisons to Cypress’s historical operating results and comparisons to
competitors’ operating results.
Cypress believes that providing these non-GAAP financial measures, in
addition to the GAAP financial results, are useful to investors because
they allow investors to see Cypress’s results “through the eyes” of
management as these non-GAAP financial measures reflect Cypress’s
internal measurement processes. Management believes that these non-GAAP
financial measures enable investors to better assess changes in each key
element of Cypress’s operating results across different reporting
periods on a consistent basis. Thus, management believes that each of
these non-GAAP financial measures provides investors with another method
for assessing Cypress’s operating results in a manner that is focused on
the performance of its ongoing operations.
There are limitations in using non-GAAP financial measures because they
are not prepared in accordance with GAAP and may be different from
non-GAAP financial measures used by other companies. In addition,
non-GAAP financial measures may be limited in value because they exclude
certain items that may have a material impact upon Cypress’s reported
financial results. Management compensates for these limitations by
providing investors with reconciliations of the non-GAAP financial
measures to the most directly comparable GAAP financial measures. The
presentation of non-GAAP financial information is not meant to be
considered in isolation or as a substitute for the most directly
comparable GAAP financial measures. The non-GAAP financial measures
supplement, and should be viewed in conjunction with, GAAP financial
measures. Investors should review the reconciliations of the non-GAAP
financial measures to their most directly comparable GAAP financial
measures as provided in the accompanying press release.
As presented in the “Reconciliation of GAAP Financial Measures to
Non-GAAP Financial Measures” tables in the accompanying press release,
each of the non-GAAP financial measures excludes one or more of the
following items:
|
|
•
|
|
Stock-based compensation expense.
|
Stock-based compensation expense relates primarily to the equity awards
such as stock options and restricted stock. Stock-based compensation is
a non-cash expense that varies in amount from period to period and is
dependent on market forces that are often beyond Cypress’s control. As a
result, management excludes this item from Cypress’s internal operating
forecasts and models. Management believes that non-GAAP measures
adjusted for stock-based compensation provide investors with a basis to
measure Cypress’s core performance against the performance of other
companies without the variability created by stock-based compensation as
a result of the variety of equity awards used by companies and the
varying methodologies and subjective assumptions used in determining
such non-cash expense.
|
|
•
|
|
Changes in value of Cypress’s key employee deferred compensation
plan.
|
Cypress sponsors a voluntary deferred compensation plan which provides
certain key employees with the option to defer the receipt of
compensation in order to accumulate funds for retirement. The amounts
are held in a trust and Cypress does not make contributions to the
deferred compensation plan or guarantee returns on the investment.
Changes in the value of the investments under the plan are excluded from
the non-GAAP measures. Management believes that such non-cash item is
not related to the ongoing core business and operating performance of
Cypress, as the investment contributions are made by the employees
themselves.
Restructuring charges primarily relate to activities engaged by
management to make changes related to its infrastructure in an effort to
reduce costs. Restructuring charges are excluded from non-GAAP financial
measures because they are not considered core operating activities and
such costs have not historically occurred in each year. Although Cypress
has engaged in various restructuring activities in the past, each has
been a discrete event based on a unique set of business objectives. As
such, management believes that it is appropriate to exclude
restructuring charges from Cypress’s non-GAAP financial measures as it
enhances the ability of investors to compare Cypress’s
period-over-period operating results from continuing operations.
|
|
•
|
|
Acquisition-related expense.
|
Acquisition-related expense primarily includes: (1) amortization of
intangibles, which include acquired intangibles such as purchased
technology, patents and trademarks, (2) costs such as advisory, legal,
accounting and other professional or consulting fees related to
acquisitions, (3) severance expense incurred in connection with
acquisition-related headcount reduction efforts, and (4) earn-out
compensation expense, which include compensation resulting from the
achievement of milestones established in accordance with the terms of
the acquisitions. In most cases, these acquisition-related charges are
not factored into management’s evaluation of potential acquisitions or
Cypress’s performance after completion of acquisitions, because they are
not related to Cypress’s core operating performance. Adjustments of
these items provide investors with a basis to compare Cypress against
the performance of other companies without the variability caused by
purchase accounting.
Cypress wrote down the book value of certain assets to their estimated
fair value as management determined these assets will be donated, sold
or will have no future benefit. Cypress excludes these items because the
expense is not reflective of its ongoing operating results. Excluding
this data allows investors to better compare Cypress’s
period-over-period performance without such expense.
|
|
•
|
|
Taxes, tax effects and foreign currency gain/loss.
|
Cypress adjusts for the income tax effect that resulted from the
non-GAAP adjustments as described above. Additionally, Cypress also
excludes the impact of items that are related to historical activities
in nature and not reflective of the ongoing operating results of
Cypress, which can include completion of examinations by our U.S. or
foreign taxing authorities, lapse of statutes of limitations and the
resolution of agreements with domestic and various foreign tax
authorities. This also includes foreign currency gain or loss effects on
the activities mentioned above.
|
|
•
|
|
Investment-related gains/losses.
|
Investment-related gains/losses primarily include: (1) impairment loss
related to Cypress’s investment when it determines the decline in fair
value is other-than-temporary in nature, and (2) gains/losses related to
the sales of its debt and equity investments. These items are excluded
from non-GAAP financial measures because they are not related to the
core operating activities and operating performance of Cypress, and in
most cases, such transactions have not historically occurred in every
quarter. As such, management believes that it is appropriate to exclude
investment-related gains/losses from Cypress’s non-GAAP financial
measures, as it enhances the ability of investors to compare Cypress’s
period-over-period operating results.
This fee relates to an agreement we entered into providing Cypress a
license to a substantial patent portfolio, avoidance of future
litigation expenses as well as future customer disruption. We determined
that a portion of the agreement relates to cumulative costs for prior
years. Management excluded the one-time charge which relates to prior
years from the non-GAAP measures because it does not relate to Cypress’
core business or impact its ongoing operating performance.
Cypress provides awards to employees who reach certain years of service
with the Company. This amount represents the accrual for benefits for
awards that will be paid in the future. This non-cash expense is not
reflective of Cypress’s ongoing operating results and is excluded from
its non-GAAP financial measures.
Copyright Business Wire 2014